Psoriasis injection Itolizumab approved for limited use in treating COVID-19: Drug Regulator
https://ift.tt/2WavxmV
India's drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, officials said.
India's drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, officials said.
No comments